# A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

> **NCT00314145** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 820 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** ChimeriVax™-JE
- **BIOLOGICAL:** JE-VAX®

## Key facts

- **NCT ID:** NCT00314145
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-06
- **Final completion:** 2006-11
- **Target enrollment:** 820 (ACTUAL)
- **Last updated:** 2012-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314145, "A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00314145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*